The Impact of the HER2 Status(HER2 Low vs HER2 Negative) on the Pathological Response to Neoadjuvant Chemotherapy in Hormonal Receptor Positive Breast Cancer.

Autor: Abdel-Aziz Mohamed, Nourhan Saeed, Abbas El-Leithy, Mahmoud Mahmoud, Ahmed Helal, Thanaa Elsayed, Mostafa, Mohamed Yassin, Abdel-Aziz, Ahmed Hassan, Elghazawy, Hagar Ibrahim

Publikováno v: QJM: An International Journal of Medicine; 2024 Supplement, Vol. 117, pii262-ii262, 1p

Resource Oriented Decision Making for Treatment of Metastatic Colorectal Cancer (mCRC) in a Lower-Middle Income Country: Egyptian Foundation of Medical Sciences (EFMS) Consensus Recommendations 2020.

Autor: Rashad N; Medical Oncology Department, Faculty of Medicine, Suez University, Suez, Egypt., Abdulla M; Clinical Oncology and Nuclear Medicine Department, Kasr Al-Aini Medical School, Cairo University, Cairo, Egypt., Farouk M; Department of Clinical Oncology, Faculty of Medicine, Alexandria University, Alexandria, Egypt., Elkerm Y; Department of Cancer Management and Research, Medical Research Institute Hospital, University of Alexandria, Alexandria, Egypt., Eid Salem S; Department of Medical Oncology, National Cancer Institute (NCI), Cairo University, Cairo, Egypt., Yahia M; Department of Medical Oncology, National Cancer Institute (NCI), Cairo University, Cairo, Egypt., Saad AS; Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Abdel Aziz AH; Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Refaat G; Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Awad I; Department of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt., ElNaggar M; Clinical Oncology Department, Assiut University Hospital, Assiut, Egypt., Kamal K; Clinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt., Refky B; Department of Surgical Oncology, Oncology Center Mansoura University, Mansoura, Egypt., Abdelkhalek M; Department of Surgical Oncology, Oncology Center Mansoura University, Mansoura, Egypt., Touny A; Department of Surgical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt., Kassem L; Clinical Oncology and Nuclear Medicine Department, Kasr Al-Aini Medical School, Cairo University, Cairo, Egypt., Shash E; Department of Medical Oncology, National Cancer Institute (NCI), Cairo University, Cairo, Egypt., Abdelhay AA; Department of Diagnostic Radiology, Cairo University, Giza, Egypt., Mahmoud BE; Department of Diagnostic Radiology, Cairo University, Giza, Egypt., Oualla K; Medical Oncology Department, Hassan II University Hospital Sidi Mohamed Ben Abdellah University, Fes, Morocco., Chraiet N; Medical Oncology Department, Salah Azaiez National Cancer Institute, Tunis, Tunisia., AwadElkarim H Maki H; Clinical Oncology Department, Ahfad University for Women, Khartoum, Sudan., Kader YA; Clinical Oncology and Nuclear Medicine Department, Kasr Al-Aini Medical School, Cairo University, Cairo, Egypt.

Publikováno v: Cancer management and research [Cancer Manag Res] 2022 Feb 28; Vol. 14, pp. 821-842. Date of Electronic Publication: 2022 Feb 28 (Print Publication: 2022).